Status:
COMPLETED
MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study
Lead Sponsor:
Duke University
Collaborating Sponsors:
North Carolina Department of Health and Human Services
Conditions:
COVID 19
Eligibility:
All Genders
18+ years
Brief Summary
The objectives of this research is to: * Assess perceptions, concerns, and practices related to the COVID-19 pandemic and mitigation strategies using the MURDOCK Study Community Registry and Biorepos...
Detailed Description
Method: Questionnaire The investigators will use RedCap to introduce the study, obtain online informed consent, and administer an electronic questionnaire to MURDOCK Study participants currently resi...
Eligibility Criteria
Inclusion
- MURDOCK Study participants ( Pro00011196) currently residing in North Carolina who have a valid email address on file.
Exclusion
- MURDOCK Study participants ( Pro00011196) currently not residing in North Carolina
- MURDOCK Study participants without a valid email address on file.
Key Trial Info
Start Date :
June 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 2 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04424004
Start Date
June 9 2020
End Date
December 2 2021
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke CTSI Translational Population Health Office
Kannapolis, North Carolina, United States, 28081